Chemical and Engineering News looked at the question of “How will FDA changes reshape drug approval ...
Compounded medications save lives. They fill critical gaps when commercial drugs are unavailable or ...
The New York Times considered how the official end of the GLP-1 shortages is affecting patients — yo...
“The GLP-1 drug shortage is over. What’s next for the compounders?” asks Pharmaceutical Technology m...
APC, along with several other organizations, has been fighting hard to protect California firefighte...
Over the last few weeks, with the FDA declaring the end of the GLP-1 shortages, APC’s reporter hotli...
In "Zepbound copycats remain online despite FDA ban," it looks at ways some compounders are continui...
How will the new administration regulate weight-loss drugs? The truth is, we don't know yet. Forbes ...
Inside Health Policy covered our letter to FDA protesting the agency's recent (ridiculous) statement...
We’re pretty happy with Newsday’s coverage of how patients taking GLP-1 drugs will be affected by th...